Skip to main content
Veterinary Medicines

Synulox Lactating Cow Intramammary suspension.

Authorised
  • Prednisolone
  • Amoxicillin trihydrate
  • Potassium clavulanate

Product identification

Medicine name:
Synulox Lactating Cow Intramammary suspension.
Synulox LC suspensija ievadīšanai tesmenī laktējošām govīm
Active substance:
  • Prednisolone
  • Amoxicillin trihydrate
  • Potassium clavulanate
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Prednisolone
    10.00
    milligram(s)
    /
    1.00
    Syringe
  • Amoxicillin trihydrate
    200.00
    milligram(s)
    /
    1.00
    Syringe
  • Potassium clavulanate
    59.56
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Milk
        60
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RV01
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Haupt Pharma Latina S.r.l.
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/MRP/98/0770
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0605/001
Concerned member states:
  • Austria
  • Bulgaria
  • Cyprus
  • Czechia
  • France
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 28/01/2022
Download

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 2/04/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."